`__________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`__________________
`
`MYLAN PHARMACEUTICALS INC.,
`Petitioner,
`
`v.
`
`MERCK SHARP & DOHME CORP.,
`Patent Owner.
`__________________
`
`Case IPR2020-00040
`U.S. Patent 7,326,708
`__________________
`
`PATENT OWNER’S AMENDED EXHIBIT LIST
`
`
`
`
`
`
`
`
`Case IPR2020-00040 | U.S. Patent 7,326,708
`
`Short Name
`
`
`Vydra Decl.
`Wenslow Decl.
`Ferlita Decl.
`Diddle Decl.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Description
`Exhibit
`EX2001 Declaration of Bruce R. Genderson in Support
`of Pro Hac Vice Admission
`EX2002 Declaration of Vicky K. Vydra
`EX2003 Declaration of Robert M. Wenslow, Ph.D.
`EX2004 Declaration of Russell R. Ferlita
`EX2005 Declaration of Joanne Diddle
`Scheduling Order, In re Sitagliptin Phosphate
`EX2006
`(’708 & ’921) Patent Litigation, No. 1:19-md-
`02902-RGA (D. Del. Aug. 23, 2019)
`EX2007 Order, Merck Sharp & Dohme Corp. v. Mylan
`Pharmaceuticals, Inc., No. 1:19-cv-00101-IMK
`(N.D. W. Va. Aug. 2, 2019)
`EX2008 Defendants’ Initial Invalidity Contentions, In re
`Sitagliptin Phosphate (’708 & ’921) Patent
`Litigation, No. 1:19-md-02902-RGA (D. Del.
`Oct. 25, 2019) (Excerpt)
`EX2009 Certified Assignment Record – US 7,326,708
`EX2010 Certified Assignment Record – WO 03/004498
`EX2011 U.S. Patent No. 9,718,880 (cited in Amgen Inc.
`v. Alexion Pharms. Inc., IPR2019-00740, Paper
`15 (P.T.A.B. Aug. 20, 2019))
`EX2012 U.S. Patent No. 7,919,499 (cited in Amneal
`Pharmaceuticals LLC v. Alkermes Pharma
`Ireland Limited, IPR2018-00943, Paper 8
`(P.T.A.B. Nov. 7, 2018))
`EX2013 U.S. Patent No. 9,182,027 (cited in Fox
`Factory, Inc. v. SRAM, LLC, IPR2016-01876,
`Paper 8 (P.T.A.B. Apr. 3, 2017))
`EX2014 Declaration of Anthony H. Sheh
`EX2015 U.S. District Court for the District of Delaware,
`Civil Docket for Case # 1:19-md-2902-RGA
`(as of April 13, 2020)
`Stipulation and [Proposed] Order to Amend
`Scheduling Order, In re Sitagliptin Phosphate
`(’708 & ’921) Patent Litigation, No. 19-2902-
`RGA (D. Del. Mar. 16, 2020), ECF No. 83
`
`EX2016
`
`1
`
`
`
`Case IPR2020-00040 | U.S. Patent 7,326,708
`
`EX2019
`
`Description
`Exhibit
`EX2017 U.S. District Court for the Northern District of
`West Virginia, Civil Docket for Case # 1:19-cv-
`00101-IMK (as of April 13, 2020)
`EX2018 Defendant’s Answer to Plaintiff’s Complaint
`and Counterclaims, Merck Sharp & Dohme
`Corp. v. Mylan Pharmaceuticals Inc., No. 19-
`cv-101-IMK (N.D. W. Va. May 31, 2019), ECF
`No. 32
`Joint Quarterly Status Report, Merck Sharp &
`Dohme Corp. v. Mylan Pharmaceuticals Inc.,
`No. 19-cv-101-IMK (N.D. W. Va. Jan. 3,
`2020), ECF No. 50
`EX2020 REDACTED VERSION, Brief in Support of
`Mylan Pharmaceuticals Inc. and Mylan Inc.’s
`Motion to Dismiss for Improper Venue and
`Failure to State a Claim, Merck Sharp &
`Dohme Corp. v. Mylan Pharmaceuticals, Inc.,
`No. 19-cv-315-RGA (D. Del. Mar. 28, 2019),
`ECF No. 15
`EX2021 U.S. Judicial Panel on Multidistrict Litigation,
`Civil Docket for Case # MDL No. 2902
`EX2022 Memorandum in Support of Motion to
`Transfer, In re Sitagliptin Phosphate (’708 &
`’921) Patent Litigation, MDL No. 2902
`(J.P.M.L. May 15, 2019), ECF No. 1-1
`In re Sitagliptin Phosphate (’708 & ’921)
`Patent Litigation, 402 F. Supp. 3d 1366
`(J.P.M.L. 2019)
`EX2024 Oral Order, Plastic Omnium Advanced
`Innovation and Research v. Donghee America
`Inc., No. 16-187-LPS (D. Del. Oct. 27, 2017),
`ECF No. 196
`
`EX2023
`
`Short Name
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`2
`
`
`
`
`
`Date: April 14, 2020
`
`
`
`
`
`Case IPR2020-00040 | U.S. Patent 7,326,708
`
`
`
`Respectfully submitted,
`
`/Stanley E. Fisher/
`Stanley E. Fisher (Reg. No. 55,820)
`Bruce R. Genderson (Pro Hac Vice)
`Jessamyn S. Berniker (Reg. No. 72,328)
`Shaun P. Mahaffy (Reg. No. 75,534)
`Anthony H. Sheh (Reg. No. 70,576)
`WILLIAMS & CONNOLLY LLP
`725 Twelfth Street, N.W.
`Washington, DC 20005
`T: (202) 434-5000
`F: (202) 434-5029
`sfisher@wc.com
`bgenderson@wc.com
`jberniker@wc.com
`smahaffy@wc.com
`asheh@wc.com
`
`Counsel for Patent Owner
`Merck Sharp & Dohme Corp.
`
`
`
`3
`
`
`
`
`
`Case IPR2020-00040 | U.S. Patent 7,326,708
`
`CERTIFICATION UNDER 37 C.F.R. § 42.24(d)
`
`Pursuant to 37 C.F.R. 42.6(e), the undersigned hereby certifies that a true and
`
`correct copy of the foregoing was served on April 14, 2020, by delivering a copy via
`
`electronic mail on the following attorneys of record:
`
`Jitendra Malik
`Alissa M. Pacchioli
`Christopher W. West
`Heike S. Radeke
`KATTEN MUCHIN ROSEMAN LLP
`550 South Tryon, Street Suite 2900
`Charlotte, NC 28202-4213
`(704) 444-2000
`jitty.malik@kattenlaw.com
`alissa.pacchioli@kattenlaw.com
`christopher.west@katten.com
`heike.radeke@katten.com
`
`/Stanley E. Fisher/
`Stanley E. Fisher
`Reg. No. 55,820
`
`
`
`
`
`
`
`4
`
`